Founded in 2021, 4Fin operates in the Fintech sector offering a lending platform catering to the financial needs of SMEs. The company focuses on providing tailored financial solutions to support small...
Funding stage:
Seed
Last funding:
28/11/2022
Total funding:
$2.10 Mn+
Revenue:
Investors
Employee count:
17
Last 90d
17
Last 90d
Web traffic:
3.75K
3.75K
Last 30d
Last 30d
4Fin: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders24
Latest Filing Date30 March 2024- Funding Events12
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of 4Fin
As of 31 March 2024, 4Fin's equity is held by 23 shareholders, with the top three being Curesense Therapeutics, Amit Tewary, and Ajit Sinha.
Curesense Therapeutics holds the largest stake in 4Fin at 29.4% as of 31 March 2024.
As of 31 March 2024, founders collectively hold 51.6% equity in 4Fin.
As of 31 March 2024, investors collectively hold 6.9% equity in 4Fin.
4Fin's ESOP pool stands at 9.5% of total equity as of 31 March 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links